Safety and Immune Response Study of the Vaccine ALVAC vCP1452 Alone or in Combination With AIDSVAX B/B
Public ClinicalTrials.gov record NCT00007332. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase II Clinical Trial to Evaluate the Immunogenicity and Safety of a Combined Regimen Using ALVAC vCP1452 and AIDSVAX B/B
Study identification
- NCT ID
- NCT00007332
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- NIH
- Enrollment
- 330 participants
Conditions and interventions
Conditions
Interventions
- ALVAC(2)120(B,MN)GNP (vCP1452) Biological
- MN rgp120/HIV-1 and GNE8 rgp120/HIV-1 Biological
Biological
Eligibility (public fields only)
- Age range
- 18 Years to 60 Years
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Not listed
- Primary completion
- Not listed
- Completion
- Mar 31, 2003
- Last update posted
- Oct 14, 2021
Ends 2003
United States locations
- U.S. sites
- 17
- U.S. states
- 10
- U.S. cities
- 12
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Alabama Vaccine CRS | Birmingham | Alabama | 35294 | — |
| San Francisco Dept. of Public Health, San Francisco Gen. Hosp. | San Francisco | California | 94102 | — |
| San Francisco Vaccine and Prevention CRS | San Francisco | California | — | — |
| Project Brave HIV Vaccine CRS | Baltimore | Maryland | 21201 | — |
| Johns Hopkins Bloomberg School of Public Health, Ctr. for Immunization Research, Project SAVE-DC | Baltimore | Maryland | 21205 | — |
| Johns Hopkins Bloomberg School of Public Health,Ctr for Immunization Research,Project SAVE-Baltimore | Baltimore | Maryland | — | — |
| Brigham and Women's Hosp. CRS | Boston | Massachusetts | 02115 | — |
| Fenway Community Health Clinical Research Site (FCHCRS) | Boston | Massachusetts | 02215 | — |
| Saint Louis Univ. School of Medicine, HVTU | St Louis | Missouri | 63110 | — |
| HIV Prevention & Treatment CRS | New York | New York | 10032 | — |
| NY Blood Ctr./Union Square CRS | New York | New York | — | — |
| Univ. of Rochester HVTN CRS | Rochester | New York | 14642 | — |
| NY Blood Ctr./Bronx CRS | The Bronx | New York | 10456 | — |
| Miriam Hospital's HVTU | Providence | Rhode Island | 02906 | — |
| Vanderbilt Vaccine CRS | Nashville | Tennessee | 37232 | — |
| Infectious Diseases Physicians, Inc. | Annandale | Virginia | 22003 | — |
| FHCRC/UW Vaccine CRS | Seattle | Washington | 98104 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00007332, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 14, 2021 · Synced May 2, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00007332 live on ClinicalTrials.gov.